cyclosporine has been researched along with Diabetic Glomerulosclerosis in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 50 (55.56) | 18.2507 |
2000's | 32 (35.56) | 29.6817 |
2010's | 7 (7.78) | 24.3611 |
2020's | 1 (1.11) | 2.80 |
Authors | Studies |
---|---|
Arnstein, M; Cooper, ME; Coughlan, MT; Forbes, JM; Granata, C; Henstridge, DC; Higgins, GC; Lindblom, RSJ; Nguyen, TV; Snelson, M; Thallas-Bonke, V | 1 |
Furuta, T; Harimoto, N; Iguchi, T; Ikeda, T; Ikegami, T; Kawanaka, H; Kuramitsu, S; Maehara, Y; Ninomiya, M; Shirabe, K; Soejima, Y; Tamada, R; Uchiyama, H; Yamashita, Y; Yoshizumi, T | 1 |
Alimoradi, H; Asgari, M; Barzegar-Fallah, A; Dehpour, AR; Razmi, A; Shafiei, M | 1 |
Dedinska, I; Krejci, K; Lackova, E; Roland, R; Zadrazil, J; Zilinska, Z | 1 |
Bautista, J; Calvo, M; Calvo, N; de la Manzanara, V; Delgado, J; Moreno, A; Perez-Flores, I; Rodriguez Cubillo, B; Rodriguez, B; Sanchez-Fructuoso, AI; Shabaka, A | 1 |
Amrein, C; Cherif, M; Chevalier, P; Glotz, D; Guillemain, R; Hill, GS; Jacquot, C; Lefaucheur, C; Nochy, D | 1 |
Akhlaghi, F; Gohh, RY; Mendonza, AE | 1 |
Amann, K; Daniel, C; Hugo, C; Stief, A; Vogelbacher, R; Wittmann, S | 1 |
Carmines, PK; Foster, JM; Pollock, JS | 1 |
Bertocchio, JP; Jaisser, F; Warnock, DG | 1 |
Döhler, B; Opelz, G | 1 |
Berrera, M; Bruschi, M; Chaykovska, L; Gabbiani, G; Ghiggeri, G; Hocher, B; Lescuyer, P; Moll, S; Prunotto, M | 1 |
Bechstein, WO; Dette, K; Lübke, P; Pridöhl, O; Woeste, G; Wullstein, C | 1 |
Abboud, HE; Barnes, JL; Garcia, S; Gooch, JL | 1 |
Akioka, K; Kadotani, Y; Nakamura, K; Ohmori, Y; Okamoto, M; Ushigome, H; Yoshimura, N | 1 |
Pannu, HS; Sandhu, JS; Singh, D | 1 |
Büsing, M; Heimes, M; Schindler, A; Schulz, T | 1 |
Anttila, VJ; Piilonen, A; Valtonen, M | 1 |
Mohaupt, MG; Saner, E; Vogt, B | 1 |
Campistol, JM; Gutierrez-Dalmau, A; Torregrosa, JV | 1 |
Malaise, J; Squifflet, JP; Van Ophem, D | 1 |
Inoue, S; Ishibashi, M; Ito, T; Kanazawa, Y; Matsuno, N; Motoyama, K; Nakajima, K; Ota, M; Sugitani, A; Tanaka, M; Yamamoto, H; Yoshida, JI | 1 |
Bechstein, WO; Berney, T; Boucek, P; Fernandez-Cruz, L; Kahl, A; Land, W; Landgraf, R; Malaise, J; Margreiter, R; Nakache, R; Saudek, F; Secchi, A; Squifflet, JP; Tydén, G; Van Ophem, D; Vanrenterghem, Y | 1 |
Cui, H; Li, GC; Liang, J; Liu, SR; Liu, YF; Meng, YM; Wu, G; Yang, L | 1 |
Cairns, TD; Dhaygude, A; Duncan, N; Griffith, M; McLean, AG; Owen, J; Palmer, A; Taube, D | 1 |
Chang, HR; Lee, MH; Lian, JD; Wen, MC | 1 |
Arbogast, H; Dieterle, C; Illner, WD; Land, W; Landgraf, R; Malaise, J; Tarabichi, A | 1 |
Claes, K; Coosemans, W; Evenepoel, P; Kuypers, DR; Maes, B; Malaise, J; Pirenne, J; Vanrenterghem, Y | 1 |
Malaise, J; Nakache, R; Van Ophem, D | 1 |
Koenigsrainer, A; Malaise, J; Margreiter, R; Mark, W; Steurer, W | 1 |
Alexander, JW; Alloway, RR; Boardman, RE; Buell, JF; Cardi, M; Gupta, M; Hanaway, M; Merchen, T; Rogers, CC; Roy-Chaudhury, P; Succop, P; Trofe, J; Woodle, ES | 1 |
Graves, JE; Nunley, JR; Phillips, MA | 1 |
Bogers, JP; Bosmans, JL; Sennesael, JJ; Verbeelen, D; Verpooten, GA | 1 |
Inoue, T; Nonoguchi, H | 1 |
Drewelow, B; Gock, M; Klar, E; Kundt, G; Schareck, W; Wacke, R | 1 |
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M | 1 |
Chambers, B; Donnan, G; Ierino, FL; Lim, AK | 1 |
Abe, M; Akamatsu, M; Babazono, T; Haruguchi, H; Hirotani, S; Kimikawa, M; Kitajima, K; Koike, T; Shinkai, M; Teraoka, S | 1 |
Benigni, A; Remuzzi, G | 1 |
Kautzky, F; Köhler, LD; Vogt, HJ | 1 |
Boonstra, JG; Bruijn, JA; Hermans, J; Lemkes, HH; Ringers, J; van der Pijl, H; van der Woude, FJ | 1 |
Reams, GP | 1 |
Ar'Rajab, A; Dawidson, I; Lu, C; Melone, D | 1 |
Benedetti, E; Gruessner, AC; Gruessner, RW; Papalois, BE; Sutherland, DE; Troppmann, C | 1 |
Ansara, MF; Brennan, DC; Cryer, PE; Flavin, KS; Lacy, PE; Scharp, DW; White, NH; Zukosky, JM | 1 |
First, MR; Hariharan, S; Schroeder, TJ | 1 |
Conway, PA; Davis, CP; Madras, PN; Monaco, AP; Sahyoun, AI; Shaffer, D; Simpson, MA | 1 |
Bilous, RW; Fioretto, P; Goetz, FC; Mauer, SM; Steffes, MW; Sutherland, DE | 1 |
Ferguson, CJ; Griffin, PJ; Moore, RH; Salaman, JR | 1 |
Barker, CF; Brayman, KL; Egidi, MF; Friedman, AL; Grossman, R; Holland, MT; Naji, A; Perloff, J; Samini, F; Tomaszewski, JE | 1 |
Ar'Rajab, A; Dawidson, I; Lu, C; Melone, D; Provost, D; Wheeler, D | 1 |
Abendroth, D; Gräb, C; Mickley, V; Steinbach, G; Storck, M | 1 |
Brennan, DC; Lowell, JA; Miller, SA; Stratta, RJ; Taylor, RJ | 1 |
Donovan, JP; Langnas, AN; Larsen, JL; Shaw, BW; Sorrell, MF; Stratta, RJ; Taylor, RJ; Trail, KC; Zetterman, RK | 1 |
Ferguson, R; Henry, M; Osei, K | 1 |
Cantarovich, D; Dantal, J; Giral, M; Hourmant, M; Karam, G; Paineau, J; Soulillou, JP | 1 |
Gores, PF; Gruessner, RW; Jones, JW; Matas, AJ | 1 |
Bia, MJ; Perazella, MA | 1 |
Fioretto, P; Gruessner, A; Kunjummen, D; Lokeh, A; Mauer, SM; Moudry-Munns, KC; Schmidt, WJ; Steffes, MW; Stevens, RB; Wang, YL | 1 |
Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Jacques, Y; Le Mauff, B; Murat, A; Paineau, J; Soulillou, JP | 1 |
Kahn, D; Lemmer, ER; Swanepoel, CR; van Zyl-Smit, R | 1 |
Lerner, L; Morris, M; Raja, RM | 1 |
Abrams, JM; Brown, RS; Shapiro, ME; Steinman, TI; Strom, TB | 1 |
Abendroth, D; Mickley, V; Steinbach, G; Storck, M | 1 |
Alejandro, R; Burke, GW; Ciancio, G; Nery, J; Ricordi, C; Roth, D; Scantlebury, V; Shapiro, R; Skyler, JS; Tzakis, A | 1 |
Beck-Nielsen, H; Birkeland, SA; Christensen, J; Dieperink, H; Jørgensen, KA; Knudsen, DU; Larsen, KE; Rohr, N; Sjølie, AK; Socci, C | 1 |
Eaton, DC; Ling, BN; Ma, H; Matsunaga, H | 1 |
Barone, GW; Ketel, BL; Reed, K; Turton-Weeks, S | 1 |
Cho, YW; Terasaki, PI | 1 |
Chen, S; Li, JW; Ma, SX; Wang, Y; Yan, YH | 1 |
Banowsky, LH; Floyd, M; Kothmann, R; Vick, S; Wright, FH | 1 |
Baçzkowska, T; Durlik, M; Gaciong, Z; Lao, M; Serafinowicz, A | 1 |
Akiyama, K; Hayashi, Y; Kushiro, M; Makino, H; Matsuda, M; Ota, Z; Shikata, K; Shikata, Y; Sugimoto, H | 1 |
Hashefi, M; Lal, SM; Luger, AM; Ross, G | 1 |
Ciurlino, D; Di Carlo, V; Gobbi, C; La Rocca, E; Pozza, G; Secchi, A | 1 |
Barrou, BM; Gruessner, AC; Gruessner, RW; Sutherland, DE | 1 |
Conti, DJ; Freed, BM; Isenberg, A; Shen, GK; Singh, TP | 1 |
Anidjar, M; Bedrossian, J; Cattan, P; Desgrandchamps, F; Fornairon, S; Le Duc, A; Legendre, C; Meria, P; Teillac, P | 1 |
Blancho, G; Cantarovich, D; Dantal, J; Giral-Classe, M; Hourmant, M; Karam, G; Le Normand, L; Soulillou, JP | 1 |
Ivić, MA; Stefanović, V | 1 |
Fisher, RK; Flechner, SM; Haug, M; Modlin, CS | 1 |
Barrou, B; Benalia, H; Bitker, MO; Chatelain, C; Grimaldi, A; Mouquet, C; Ourahma, S; Richard, F | 1 |
Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S | 1 |
Jauhari, H; Singh, S; Wadhawan, S | 1 |
Abraham, G; Eapen, G; Hinduja, A; Kuruvilla, S; Rao, R; Shroff, S | 1 |
Dequiedt, P; Fontaine, P; Guillem, P; Pruvot, FR; Vlaeminck-Guillem, V | 1 |
Arap, S; Fonseca, JA; Ianhez, LE; Sabbaga, E | 1 |
Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Murat, A; Paineau, J; Soulillou, JP | 1 |
Becker, HD; Büsing, M; Hopt, UT; Irkin, I; Pfeffer, F; Schareck, W | 1 |
Field, MJ; Kaufman, DB; Morel, P; Nakai, I; Sutherland, DE | 1 |
9 review(s) available for cyclosporine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Cyclosporine; Diabetic Nephropathies; Humans; Kidney Diseases; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Proteinuria; Receptors, Mineralocorticoid; Renin-Angiotensin System | 2011 |
Renal fibrosis and proteomics: current knowledge and still key open questions for proteomic investigation.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetic Nephropathies; Fibrosis; Glomerulonephritis; Humans; Hypoxia; Kidney; Kidney Diseases; Kidney Failure, Chronic; Proteomics; Transforming Growth Factor beta | 2011 |
Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine.
Topics: Adult; Alopecia Areata; Cyclosporine; Diabetic Nephropathies; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation | 2005 |
[Molecular biology in regulation of kidney functions: VEGF (vascular endothelial growth factor)].
Topics: Animals; Cyclosporine; Diabetic Nephropathies; Glomerulonephritis, Membranoproliferative; Hemolytic-Uremic Syndrome; Humans; Kidney; Kidney Diseases; Vascular Endothelial Growth Factor A | 2006 |
Endothelin in the progressive renal disease of glomerulopathies.
Topics: Animals; Cyclosporine; Diabetic Nephropathies; Endothelins; Glomerulonephritis; Humans; Kidney; Receptors, Endothelin; Ureteral Obstruction | 1995 |
Do calcium channel blockers have renal protective effects?
Topics: Aging; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Cyclosporine; Diabetic Nephropathies; Dihydropyridines; Diltiazem; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Transplantation; Rats; Rats, Inbred SHR; Verapamil | 1994 |
Posttransplant erythrocytosis: case report and review of newer treatment modalities.
Topics: Blood Volume; Bloodletting; Combined Modality Therapy; Cyclosporine; Diabetic Nephropathies; Diuretics; Erythrocyte Volume; Erythropoietin; Feedback; Humans; Iron Deficiencies; Kidney Transplantation; Male; Middle Aged; Polycythemia; Postoperative Complications; Theophylline | 1993 |
Role of growth factors in mesangial cell ion channel regulation.
Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Cyclosporine; Diabetic Nephropathies; Endothelins; Furosemide; Glomerular Mesangium; Growth Substances; Humans; Insulin; Ion Channels; Ion Transport; Models, Biological; Receptors, Angiotensin | 1995 |
Endothelins in hypertension and kidney diseases.
Topics: Acute Kidney Injury; Animals; Contrast Media; Cyclosporine; Diabetic Nephropathies; Endothelins; Glomerulonephritis; Humans; Hypertension; Kidney Diseases | 1998 |
16 trial(s) available for cyclosporine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
[TAC/MMF/Pred/single shot ATG versus CsA/MMF/Pred single shot ATG after pancreas-/kidney transplantation (PNTX)--initial results of a prospective randomized study].
Topics: Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Prospective Studies; Tacrolimus; Treatment Outcome | 1998 |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Emulsions; Europe; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Israel; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Safety; Tacrolimus | 2004 |
Rejection after simultaneous pancreas-kidney transplantation.
Topics: Adolescent; Adult; Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease-Free Survival; Drug Therapy, Combination; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Complications; Tacrolimus | 2005 |
Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Topics: Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Leukocyte Count; Mycophenolic Acid; Pancreas Transplantation; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
A large, prospective, randomized, open-label, multicentre study of corticosteroid withdrawal in SPK transplantation: a 3-year report.
Topics: Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Europe; Feasibility Studies; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Israel; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Prospective Studies; Safety; Tacrolimus; Time Factors; Treatment Outcome; Withholding Treatment | 2005 |
Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Europe; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Israel; Kidney Failure, Chronic; Kidney Transplantation; Laparotomy; Middle Aged; Pancreas Transplantation; Postoperative Complications; Prospective Studies; Reoperation; Survival Rate; Tacrolimus; Treatment Outcome | 2005 |
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetic Nephropathies; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lymphocele; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Wound Healing | 2005 |
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
Topics: Adult; Amylases; Biomarkers; Blood Glucose; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Recurrence; Tacrolimus; Time Factors; Tissue Donors; Urine | 1995 |
Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Monitoring; Female; Graft Rejection; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Pancreas Transplantation; Probability; Survival Rate | 1995 |
Modification of methodology results in improvement in simultaneous kidney-islet success.
Topics: Antilymphocyte Serum; Azathioprine; C-Peptide; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppression Therapy; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Failure, Chronic; Kidney Transplantation; Muromonab-CD3; Postoperative Complications; Prednisone; Tissue Preservation; Transplantation, Heterotopic; Transplantation, Homologous | 1995 |
Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Administration Schedule; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Predictive Value of Tests; Prednisone | 1994 |
Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation.
Topics: Administration, Oral; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Pancreas Transplantation; Radioimmunoassay | 1994 |
Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
Topics: Actuarial Analysis; Adult; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Histocompatibility Testing; Humans; Immunosuppression Therapy; Interleukin-2; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Rabbits; Survival Analysis; Time Factors | 1993 |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.
Topics: Blood Glucose; C-Peptide; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Tacrolimus | 1995 |
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prospective Studies; Rabbits; Safety | 1998 |
Renal transplantation in diabetic patients: a survey of 100 cases.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Kidney Transplantation; Male; Prednisone; Retrospective Studies; Survival Analysis; Time Factors | 1992 |
65 other study(ies) available for cyclosporine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D.
Topics: Albuminuria; Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydrogen Peroxide; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; Proton-Translocating ATPases | 2020 |
[Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
Topics: Cyclosporine; Diabetic Nephropathies; Female; Hepatitis B; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Cirrhosis; Liver Transplantation; Living Donors; Middle Aged; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome | 2014 |
Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Hypertrophy; Indoles; Kidney Glomerulus; Male; Protective Agents; Rats; Streptozocin; Transcription Factors; Tropisetron | 2015 |
Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients.
Topics: Cyclosporine; Delayed-Action Preparations; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Substitution; Dyslipidemias; Female; Gingival Hyperplasia; Glomerular Filtration Rate; Hirsutism; Humans; Hypertension, Renal; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Treatment Outcome | 2016 |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cyclosporine; Diabetic Nephropathies; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Tacrolimus | 2016 |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis.
Topics: Biopsy; Cyclosporine; Cystic Fibrosis; Diabetic Nephropathies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Kidney Glomerulus; Kidney Tubules; Lung Transplantation; Retrospective Studies; Tacrolimus | 2008 |
Blood and plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients.
Topics: Cyclosporine; Diabetic Nephropathies; Female; Gastric Emptying; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 2008 |
Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Primers; Fibronectins; Immunosuppressive Agents; Laminin; Male; Nephrogenic Fibrosing Dermopathy; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sirolimus; Vascular Endothelial Growth Factor A | 2009 |
PP2B-dependent NO production in the medullary thick ascending limb during diabetes.
Topics: Amidines; Animals; Benzylamines; Calcineurin; Calcineurin Inhibitors; Cell Survival; Cyclic N-Oxides; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Kidney Medulla; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Ornithine; Phosphorylation; Rats; Rats, Sprague-Dawley; Spin Labels; Up-Regulation | 2009 |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Diabetic Nephropathies; Female; Graft Rejection; Hip Fractures; Histocompatibility Testing; HLA-DR Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Treatment Outcome | 2011 |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisolone; Prednisone; Tacrolimus; Time Factors; Treatment Failure; Treatment Outcome | 2002 |
Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Extracellular Matrix; Fibronectins; Gene Expression; Hypertrophy; Kidney Glomerulus; Male; Phosphoric Monoester Hydrolases; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2003 |
Renal transplant recipient experiencing pneumatosis cystoides intestinalis: a case report.
Topics: Barium; Cyclosporine; Diabetic Nephropathies; Drug Therapy, Combination; Enema; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pneumatosis Cystoides Intestinalis; Postoperative Complications; Tacrolimus | 2003 |
Lipid profile before and after renal transplantation--a longitudinal study.
Topics: Adult; Azathioprine; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerulonephritis; Graft Rejection; Humans; Hypercholesterolemia; Hypertension, Renal; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; India; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Nephrosclerosis; Polycystic Kidney Diseases; Prednisolone; Time Factors; Treatment Outcome; Triglycerides | 2003 |
Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection.
Topics: Aspergillosis; Caspofungin; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Immunocompromised Host; Kidney Transplantation; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides; Peptides, Cyclic; Risk Assessment; Treatment Outcome | 2003 |
[Irritant cough and sub-febrile temperature under immunosuppression].
Topics: Anti-Inflammatory Agents; Body Temperature; Bronchoalveolar Lavage Fluid; Bronchoscopy; Coronary Artery Bypass; Cough; Cyclosporine; Diabetic Nephropathies; Diagnosis, Differential; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Middle Aged; Prednisone; Radiography, Thoracic; Risk Factors; Sirolimus; Tomography, X-Ray Computed; Xenobiotics | 2004 |
Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.
Topics: Aged; Antibiotics, Antineoplastic; Cyclosporine; Diabetic Nephropathies; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Sarcoma, Kaposi; Sirolimus | 2004 |
The use of cyclosporine in renal and pancreas transplantation.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation; Retrospective Studies; Survival Analysis | 2004 |
Pancreas-kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Humans; Immunosuppressive Agents; Japan; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
[Analysis of rejection after simultaneous pancreas-kidney transplantation].
Topics: Administration, Oral; Adult; Azathioprine; Cyclosporine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prednisolone; Retrospective Studies; Transplantation, Homologous | 2004 |
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Topics: Adult; Albuminuria; Cyclosporine; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Proteinuria; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Reoperation; Sirolimus; Tacrolimus; Treatment Outcome | 2004 |
Conversion from cyclosporine to sirolimus in stable renal transplant recipients.
Topics: Adult; Aged; Creatinine; Cyclosporine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus | 2005 |
Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.
Topics: Area Under Curve; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Emulsions; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Postoperative Period; Prednisone; Regression Analysis; Reproducibility of Results | 2006 |
The CARI guidelines. Prevention of progression of kidney disease.
Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy | 2006 |
Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
Topics: Adult; Cyclosporine; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Prednisolone; Recurrence; Thymectomy | 2007 |
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation].
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms | 1995 |
The incidence of interstitial and vascular kidney rejection after pancreas-kidney transplantation.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Diabetic Nephropathies; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Matched-Pair Analysis; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Prednisone | 1995 |
Early endocrine pancreas graft function and outcome after simultaneous pancreas-kidney transplantation.
Topics: Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Humans; Insulin; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Prednisone; Retrospective Studies; Tissue Donors; Treatment Outcome | 1995 |
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Azathioprine; Biological Availability; Cyclosporine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 1995 |
Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
Topics: Actuarial Analysis; Boston; Cardiovascular Diseases; Cause of Death; Creatinine; Cyclosporine; Diabetes Mellitus; Diabetic Nephropathies; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Retrospective Studies; Survival Rate; Tissue Donors; Treatment Outcome | 1995 |
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.
Topics: Adolescent; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Mesangium; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Glomerulus; Male; Middle Aged; Pancreas Transplantation; Time Factors | 1993 |
Effect of pancreas transplantation on glomerular structure in diabetes.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney Glomerulus; Pancreas Transplantation | 1994 |
Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation; Prednisone; Retrospective Studies; Time Factors | 1994 |
Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Humans; Kidney Transplantation; Male; Pancreas Transplantation; Proteinuria | 1994 |
Orthotopic hepatic transplantation in patients with type I diabetes mellitus.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Transplantation; Male; Pancreas Transplantation; Prednisone; Risk Factors; Survival Rate | 1994 |
Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.
Topics: Adult; Azathioprine; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glucose; Homeostasis; Humans; Immunotherapy; Insulin; Insulin Resistance; Kidney Transplantation; Kinetics; Male; Pancreas Transplantation; Prednisone; Tolbutamide; Transplantation, Heterotopic | 1994 |
OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Prednisolone | 1994 |
Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
Topics: Adult; Aldosterone; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Fludrocortisone; Humans; Hyperkalemia; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Potassium; Renin | 1993 |
Correlation of preoperative renal function and identification of risk factors for eventual native renal failure in cyclosporine-treated nonuremic diabetic recipient of pancreas transplants alone.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Pancreas Transplantation; Retrospective Studies; Risk Factors | 1993 |
Transplantation for diabetic nephropathy at Groote Schuur Hospital.
Topics: Adult; Cyclosporine; Diabetic Nephropathies; Female; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1993 |
Hypertension with combined pancreas-kidney transplantation in patients with diabetic nephropathy.
Topics: Cyclosporine; Diabetic Nephropathies; Female; Humans; Hypertension; Kidney Transplantation; Male; Pancreas Transplantation | 1993 |
Successful pancreas-renal transplantation without anti-T-cell antibody induction.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetic Nephropathies; Female; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Prednisone; T-Lymphocytes | 1995 |
Cyclosporine resorption in diabetic patients after simultaneous pancreas and kidney transplantation.
Topics: Adult; Biological Availability; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gastroparesis; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Middle Aged; Pancreas Transplantation | 1995 |
Islet and kidney transplantation using ATG and cyclosporin monotherapy and a central facility for islet isolation and purification.
Topics: Adult; Antilymphocyte Serum; Blood Glucose; C-Peptide; Cell Separation; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Middle Aged; T-Lymphocytes | 1995 |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Time Factors | 1996 |
Comparison of kidney graft survival in Asian and Caucasian patients transplanted in the United States.
Topics: Adolescent; Adult; Age Factors; Asia; Cyclosporine; Cytomegalovirus Infections; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organ Preservation; Regression Analysis; Risk Factors; Sex Factors; Survival Rate; Tissue Donors; United States; White People | 1996 |
Effect of new thromboxane A2 synthesis inhibitor tetramethyl-pyrazine on pancreatic transplantation in diabetic rats.
Topics: Albuminuria; Animals; Benzofurans; beta 2-Microglobulin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Organ Size; Pancreas Transplantation; Pyrazines; Rats; Rats, Wistar; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Isogeneic | 1996 |
Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Topics: Actuarial Analysis; Adolescent; Adult; Age Factors; Antilymphocyte Serum; Cadaver; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Retrospective Studies; Tissue Donors | 1996 |
Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Topics: Administration, Oral; Biological Availability; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Clearance Rate | 1996 |
A case of early-stage diabetic nephropathy complicated by minimal change nephrotic syndrome treated with cyclosporin A.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrosis, Lipoid | 1997 |
De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case.
Topics: Basement Membrane; Cyclosporine; Diabetic Nephropathies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Male; Microscopy, Fluorescence; Middle Aged; Tacrolimus; Treatment Outcome | 1997 |
Improvement of glucose/insulin metabolism reduces hypertension in insulin-dependent diabetes mellitus recipients of kidney-pancreas transplantation.
Topics: Adult; Blood Glucose; Cause of Death; Chi-Square Distribution; Cohort Studies; Cyclosporine; Cystostomy; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Duodenostomy; Female; Follow-Up Studies; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Retrospective Studies | 1998 |
Pregnancy after pancreas transplantation in the cyclosporine era: report from the International Pancreas Transplant Registry.
Topics: Adult; Age of Onset; Birth Weight; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Immunosuppressive Agents; Infant, Newborn; International Cooperation; Kidney Transplantation; Pancreas Transplantation; Pregnancy; Pregnancy Outcome; Registries | 1998 |
Selective CellCept therapy in high-risk renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Prednisone; Reoperation; Retrospective Studies; Survival Rate | 1998 |
Can we improve the results of simultaneous pancreas-kidney transplantation?
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Organ Preservation; Pancreas; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 1998 |
Cyclosporine disposition and long-term renal function in a 500-pound kidney transplant recipient.
Topics: Biological Availability; Cadaver; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid | 1998 |
[Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Analysis; Tacrolimus; Treatment Outcome | 1999 |
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2000 |
Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
Topics: Cyclosporine; Diabetic Nephropathies; Graft Survival; Humans; Immunosuppressive Agents; India; Kidney Failure, Chronic; Kidney Transplantation; Retrospective Studies; Time Factors | 2000 |
An early experience with Simulect (basiliximab): an IL-2 receptor antibody.
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prednisolone; Receptors, Interleukin-2; Recombinant Fusion Proteins; Retrospective Studies | 2000 |
Liver transplantation eliminates insulin needs of a diabetic patient.
Topics: Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glomerulonephritis; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Insulin; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Postoperative Period | 2000 |
Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Graft Rejection; Humans; Immunosuppression Therapy; Interleukin-2; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Receptors, Interleukin-2; Uremia | 1992 |
Is HLA matching worthwhile in pancreatic transplantation?
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Pancreas Transplantation; Retrospective Studies; Time Factors; Treatment Outcome | 1992 |
Differential effects of preexisting uremia and a synchronous kidney graft on pancreas allograft functional survival in rats.
Topics: Animals; Cyclosporine; Diabetic Nephropathies; Graft Rejection; Graft Survival; Kidney; Kidney Transplantation; Male; Pancreas Transplantation; Rats; Rats, Inbred Lew; Transplantation, Homologous; Uremia | 1992 |